MRA Advisory Group’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,875
Closed -$206K 107
2023
Q4
$206K Sell
1,875
-1,580
-46% -$158K 0.14% 94
2023
Q3
$335K Buy
3,455
+104
+3% +$10.9K 0.24% 80
2023
Q2
$365K Sell
3,351
-910
-21% -$97K 0.25% 67
2023
Q1
$431K Sell
4,261
-656
-13% -$69.3K 0.31% 56
2022
Q4
$540K Sell
4,917
-514
-9% -$53.2K 0.42% 50
2022
Q3
$549K Buy
5,431
+61
+1% +$6.5K 0.47% 46
2022
Q2
$583K Sell
5,370
-472
-8% -$53.6K 0.51% 40
2022
Q1
$691K Sell
5,842
-20
-0.3% -$2.48K 0.52% 39
2021
Q4
$825K Buy
5,862
+839
+17% +$107K 0.64% 34
2021
Q3
$593K Buy
5,023
+383
+8% +$47K 0.5% 43
2021
Q2
$538K Sell
4,640
-231
-5% -$26.9K 0.46% 45
2021
Q1
$584K Buy
4,871
+480
+11% +$56.9K 0.55% 43
2020
Q4
$481K Buy
+4,391
New +$477K 0.47% 49

Other funds holding ABT

MRA Advisory Group's ABT Position: Q1 2024 in Review

MRA Advisory Group sold out of Abbott (ABT) in Q1 2024, closing a stake of 1,875 shares — an estimated $206K sold.

MRA Advisory Group first reported a position in ABT in Q4 2020 and held it in 13 quarters. The position peaked at $825K in Q4 2021. 2,904 funds tracked by Wall St. Rank hold ABT as of Q1 2024.

  • MRA Advisory Group reported no remaining Abbott position as of Q1 2024 after selling out during the quarter.
  • MRA Advisory Group sold 1,875 Abbott shares in Q1 2024, an estimated $206K.
  • MRA Advisory Group first reported a position in Abbott in Q4 2020 and held it in 13 quarters.
  • MRA Advisory Group's Abbott position peaked at $825K in Q4 2021.
  • 2,904 funds tracked by Wall St. Rank held Abbott as of Q1 2024.

Based on MRA Advisory Group's 13F filing for Q1 2024, filed 3 May 2024.